What is Ponatinib?

Category: Prescription Drugs

Most popular types: Iclusig


Ponatinib is a kinase inhibitor that may be used for treatment of adults with chronic-, accelerated-, or blast-phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or for Ph+ALL that is resistant or intolerant to prior TKI treatment.


Based on patients currently taking Ponatinib

Dosage Patients
45 mg daily 1


Currently taking Ponatinib

Duration Patients
1 - 2 years 1

What people switch to and from

Patients started taking Ponatinib after stopping:

Treatment Patients
Imatinib (Gleevec) 1
Last updated:
There are no evaluations for Ponatinib.